Growth Metrics

Surgery Partners (SGRY) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Surgery Partners (SGRY) over the last 12 years, with Q3 2025 value amounting to -$0.18.

  • Surgery Partners' EPS (Weighted Average and Diluted) rose 2800.0% to -$0.18 in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.36, marking a year-over-year decrease of 18936.17%. This contributed to the annual value of $0.1 for FY2024, which is 21012.27% up from last year.
  • According to the latest figures from Q3 2025, Surgery Partners' EPS (Weighted Average and Diluted) is -$0.18, which was up 2800.0% from -$0.02 recorded in Q2 2025.
  • Surgery Partners' EPS (Weighted Average and Diluted)'s 5-year high stood at $0.37 during Q4 2023, with a 5-year trough of -$0.57 in Q1 2021.
  • For the 5-year period, Surgery Partners' EPS (Weighted Average and Diluted) averaged around -$0.15, with its median value being -$0.2 (2023).
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first skyrocketed by 25490.7% in 2023, then tumbled by 52500.0% in 2024.
  • Surgery Partners' EPS (Weighted Average and Diluted) (Quarter) stood at $0.07 in 2021, then tumbled by 442.86% to -$0.24 in 2022, then soared by 254.91% to $0.37 in 2023, then plummeted by 199.38% to -$0.37 in 2024, then surged by 51.28% to -$0.18 in 2025.
  • Its last three reported values are -$0.18 in Q3 2025, -$0.02 for Q2 2025, and -$0.3 during Q1 2025.